Loading...
FONAR Corporation
FONR•NASDAQ
Healthcare
Medical - Devices
$16.07
$0.20(1.26%)
FONAR Corporation (FONR) Financial Performance & Income Statement Overview
Review FONAR Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.30%
↑ 4.30%
Operating Income Growth
11.81%
↑ 11.81%
Net Income Growth
12.71%
↑ 12.71%
Operating Cash Flow Growth
-2.58%
↓ 2.58%
Operating Margin
15.46%
↑ 15.46%
Gross Margin
35.31%
↑ 35.31%
Net Profit Margin
14.21%
↑ 14.21%
ROE
8.77%
↑ 8.77%
ROIC
-85.72%
↓ 85.72%
FONAR Corporation (FONR) Income Statement & Financial Overview
Review FONAR Corporation's (FONR) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $2.02M | $24.95M | $24.96M | $25.94M |
| Cost of Revenue | $4.90M | $15.21M | $14.92M | $15.35M |
| Gross Profit | -$2.88M | $9.74M | $10.04M | $10.60M |
| Gross Profit Ratio | -$1.42 | $0.39 | $0.40 | $0.41 |
| R&D Expenses | $441000.00 | $376000.00 | $307000.00 | $438949.00 |
| SG&A Expenses | $7.99M | $6.93M | $5.13M | $8.82M |
| Operating Expenses | $18.60M | $7.30M | $5.44M | $9.26M |
| Total Costs & Expenses | $23.50M | $22.52M | $20.35M | $24.61M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$7000.00 | $6000.00 | $8000.00 | $9997.00 |
| Depreciation & Amortization | $0.00 | $202000.00 | $2.10M | $2.08M |
| EBITDA | $3.66M | $3.17M | $7.35M | $4.008M |
| EBITDA Ratio | $1.81 | $0.13 | $0.29 | $0.15 |
| Operating Income | $3.66M | $2.44M | $4.61M | $1.33M |
| Operating Income Ratio | $1.81 | $0.10 | $0.18 | $0.05 |
| Other Income/Expenses (Net) | $468000.00 | $532000.00 | $643000.00 | $586021.00 |
| Income Before Tax | $4.13M | $2.97M | $5.25M | $1.92M |
| Income Before Tax Ratio | $2.04 | $0.12 | $0.21 | $0.07 |
| Income Tax Expense | -$1.006M | $762000.00 | $1.25M | $284968.00 |
| Net Income | $5.14M | $1.96M | $3.13M | $830396.00 |
| Net Income Ratio | $2.54 | $0.08 | $0.13 | $0.03 |
| EPS | $0.11 | $0.29 | $0.47 | $0.12 |
| Diluted EPS | $0.37 | $0.29 | $0.46 | $0.11 |
| Weighted Avg Shares Outstanding | $6.17M | $6.30M | $6.30M | $6.77M |
| Weighted Avg Shares Outstanding (Diluted) | $6.30M | $6.43M | $6.43M | $7.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan